GNVC FINALS
The Global New Venture Challenge (GNVC), the Executive MBA track of the Edward L. Kaplan, ’71, New Venture Challenge (NVC), returns to the Gleacher Center for the finals of this year-long process. Join the Polsky Center for Entrepreneurship and Innovation and the Executive MBA Program office for the 2018 GNVC Finals on Thursday, April 12. Six top teams from Chicago Booth’s London, Hong Kong, and Chicago campuses will pitch before a panel of judges and compete for more than $50,000 in cash prizes.
The Polsky Center supports student and alumni globally in initiatives to support entrepreneurship. With locations in Chicago, London, and Hong Kong, Chicago Booth’s Executive MBA Program allows students to connect with experienced professionals from across the globe. Now celebrating its 75th anniversary, the Executive MBA at Chicago Booth allows students to spend time at all three campuses, building their general management skills and broadening global networks. The Global New Venture Challenge finals take place during graduation week for the Executive MBAs (XP87, EXP23, AXP17).
The teams competing at the finals are:
- Altris.AI (London Campus): A product that uses a deep learning and AI to improve the diagnostic process in ophthalmology.
- Dr. Mo (London Campus): A novel electromagnetic engine technology creating faster, cleaner motorcycles.
- HomePro (Hong Kong Campus): A home-based nursing and therapy care provider to elders in China promoting better patient outcomes and reducing the burden of care for their family.
- Mindful Urgent Care (Chicago Campus): A walk-in psychiatric clinic providing same-day, non-emergency, mental health, substance abuse, and psychiatric services to insured and cash-paying clients.
- Verity Technologies (Chicago Campus): A healthcare technology company that is working on harnessing the power of Virtual Reality to provide treatment solutions for pain management/rehabilitation.
- WalletKo (Hong Kong Campus): A mobile app that enables overseas foreign workers to instantly send money to beneficiaries in the Philippines up to 8x cheaper than traditional methods.